CJ DeKreek

CJ leads the life sciences valuation sector at Ankura, advising biotechnology, pharmaceutical, and medical device companies on the valuation issues they face. He routinely consults with life sciences clients to provide compliance guidance and supportable fair market value analyses in connection with the complex relationships underlying payments to and from customers.

This experience includes valuations of fee-for-service arrangements, including bona fide service fees, for services performed for life sciences companies and provided by various market access channel partners, including specialty pharmacies, specialty distributors, third-party logistics, wholesalers, group purchasing organizations, HUBs, data providers, copay program administrators, and pharmacy benefit managers, among others.

CJ’s expertise also includes assisting clients with developing and documenting fair market value hourly rates and other payments to healthcare professionals for consulting on product development, serving on advisory boards, and conducting speaker programs, as well as providing other consulting services.

In addition, CJ has a broad range of corporate finance experience, including exclusive sale transactions, financings, strategic advisory services, financial restructurings, valuations, and fairness opinions to clients in a wide variety of industries, including life sciences, healthcare, homebuilding, paper and packaging, technology, and consumer products.